Lucintel Forecasts the Global Brain Cancer Diagnostic Market to reach $9.3 billion by 2030

According to a market report by Lucintel, the future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 with a CAGR of 23.7% from 2024 to 2030. The major drivers for this market are increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

A more than 150-page report to understand trends, opportunity and forecast in brain cancer diagnostic market to 2030 by test type (imaging test, biopsy, lumber puncture, molecular testing, electroencephalography, and others), cancer type (acoustic neuroma, astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others), age group (children, adult, and geriatic), end use (hospitals, specialty clinics, diagnostic centers & research institutes, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the cancer type category, glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.

Within the end use category, hospitals is expected to witness the highest growth over the forecast period due to increasing prevalence of brain cancer, improvement in the hospital infrastructure, and rising investments and funding in cancer diagnostics.

Download sample by clicking on brain cancer diagnostic market

In terms of regions, North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.

Thermo Fisher Scientific, Siemens Healthcare Diagnostics, Hologic, Nantomics, GE Healthcare, Nihon Kohden, Canon, Fujifilm Holdings are the major suppliers in the brain cancer diagnostic market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056

Explore Our Latest Publications

Industrial Serial Data Fiber Optic Converter Market

Serial Data Fiber Optic Converter Market

3T MRI Scanner Market

Absorbable Tissue Spacer Market

Acousto-optic Device Market

 

Leave a Reply

Your email address will not be published. Required fields are marked *